Vivo Ventures Fund VII, L.P.
Insider CIK 1509160 · CDXS 10% owner · MEIP 10% owner · SRRA Director, 10% owner · AXP 10% owner · ACRS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 75,749 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 324,740 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,455,384 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 2,735,853 | $55.00 | $150.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 431,947 | $55.00 | $23.76M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 161,712 | $55.00 | $8.89M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 800,000 | $27.00 | $21.60M | 2,735,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 1,455,384 | $13.20 | $19.21M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 324,740 | $13.20 | $4.29M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 75,749 | $13.20 | $999.9K | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 107,164 | $13.20 | $1.41M | 431,947 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 24,996 | $13.20 | $329.9K | 161,712 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 480,277 | $13.20 | $6.34M | 1,935,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 1,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 4,287 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,213 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,455,576 | — | $0 | 1,455,576 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 324,783 | — | $0 | 324,783 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 75,759 | — | $0 | 136,715 | SEC↗ |
| AXP AIRXPANDERS INC | P Buy | 2018-08-30 | 2018-08-31 | 19,712,492 | $0.17 | $3.35M | 36,195,409 | SEC↗ |
| AXP AIRXPANDERS INC | P Buy | 2018-08-30 | 2018-08-31 | 429,631 | $0.17 | $73.0K | 788,873 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2017-09-14 | 2017-09-18 | 1,037,390 | $5.78 | $6.00M | 4,144,495 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2017-09-14 | 2017-09-18 | 22,610 | $5.78 | $130.7K | 90,330 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-03-02 | 2017-03-02 | 2,666 | $31.20 | $83.2K | 60,972 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-03-02 | 2017-03-02 | 122,334 | $31.20 | $3.82M | 2,797,597 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 2,133 | $30.98 | $66.1K | 63,638 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-03-01 | 2017-03-02 | 97,867 | $30.98 | $3.03M | 2,919,931 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 4,266 | $30.50 | $130.1K | 65,771 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2017-02-28 | 2017-03-02 | 195,734 | $30.50 | $5.97M | 3,017,798 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-11-18 | 2016-11-18 | 440,402 | $22.72 | $10.01M | 3,213,532 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-11-18 | 2016-11-18 | 9,598 | $22.72 | $218.1K | 70,037 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-11-16 | 2016-11-18 | 9,765 | $27.30 | $266.6K | 79,635 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2016-11-16 | 2016-11-18 | 448,063 | $23.25 | $10.42M | 3,653,934 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-09-08 | 2016-09-12 | 2,381 | $4.25 | $10.1K | 112,940 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-09-08 | 2016-09-12 | 109,219 | $4.25 | $464.2K | 5,181,885 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-16 | 2016-08-17 | 36,107 | $4.21 | $152.0K | 5,291,104 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-16 | 2016-08-17 | 787 | $4.21 | $3.3K | 115,321 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-15 | 2016-08-17 | 1,066 | $4.27 | $4.6K | 116,108 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-15 | 2016-08-17 | 48,934 | $4.27 | $208.9K | 5,327,211 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-04 | 2016-08-05 | 1,066 | $4.17 | $4.4K | 117,174 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-04 | 2016-08-05 | 48,934 | $4.17 | $204.1K | 5,376,145 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-03 | 2016-08-05 | 640 | $4.30 | $2.8K | 118,240 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2016-08-03 | 2016-08-05 | 29,360 | $4.30 | $126.2K | 5,425,079 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 38,782 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 8,467,943 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 184,557 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 1,779,400 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 29,337 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 1,346,068 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 444,850 | $11.00 | $4.89M | 4,101,997 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 73,238 | — | $0 | 79,705 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 9,695 | $11.00 | $106.6K | 89,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 3,360,408 | — | $0 | 3,657,147 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-07 | 2015-10-09 | 285 | $11.00 | $3.1K | 6,467 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-07 | 2015-10-09 | 13,067 | $11.00 | $143.7K | 296,739 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion deriv | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion deriv | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 0 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion | 2015-07-21 | 2015-07-21 | 2,064,308 | — | $0 | 2,064,308 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | C Conversion | 2015-07-21 | 2015-07-21 | 44,991 | — | $0 | 2,109,299 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | J Other | 2015-07-21 | 2015-07-21 | 2,324 | $5.22 | $12.1K | 2,218,270 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | P Buy | 2015-07-21 | 2015-07-21 | 215,307 | $17.00 | $3.66M | 2,433,577 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | P Buy | 2015-07-21 | 2015-07-21 | 4,693 | $17.00 | $79.8K | 2,438,270 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | J Other | 2015-07-21 | 2015-07-21 | 106,647 | $5.22 | $556.7K | 2,215,946 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-10-29 | 2013-10-29 | 756 | $8.27 | $6.3K | 3,098,503 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-10-28 | 2013-10-29 | 38,953 | $8.30 | $323.3K | 3,099,259 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-10-25 | 2013-10-29 | 259,900 | $8.20 | $2.13M | 3,138,212 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-10-02 | 2013-10-03 | 486,107 | $10.00 | $4.86M | 3,398,112 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-10-01 | 2013-10-03 | 95,539 | $11.00 | $1.05M | 3,884,219 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-06-28 | 2013-07-02 | 7,337 | $7.58 | $55.6K | 3,979,758 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-06-11 | 2013-06-13 | 236,273 | $7.80 | $1.84M | 3,987,095 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-05-16 | 2013-05-20 | 17,428 | $9.07 | $158.1K | 4,223,368 | SEC↗ |